Tuscany Region Publishes Three Rapid HTAs with Favorable Recommendations in October 2026

In October 2026, the Tuscany Regional Healthcare Authority published three new rapid HTA reports under Regional Decree No. 22532, covering medical devices used in cardiovascular and peripheral vascular procedures.

Tuscany remains one of the most active Italian regions in conducting HTAs of medical devices, with HTA-based recommendations informing regional adoption and procurement decisions.

All three assessed technologies received favorable purchase recommendations.

Examples of the evaluated devices include:

• Trilogy Transcatheter Aortic Valve System (JenaValve Technology): A transcatheter heart valve system for aortic valve replacement.
• Esprit BTK Everolimus-Eluting Resorbable Scaffold System (Abbott): A bioresorbable, drug-eluting scaffold designed for below-the-knee peripheral arterial interventions.

This news is just one of about 300 market access news and updates collected by our team in the premium subscription service MTRC Access Intelligence every week from more than 80 organizations. Access our paid service to stay on top of all developments, specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, six-week, no-obligation trial.